AstraZeneca makes surprise U-turn with £300m pharma investment
Drugmaker had stalled large-scale UK projects but has now pledged investment at two sites, announced by Keir Starmer Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year. The drugmaker had pulled back projects in Britain after becoming disillusioned with the business environment, including the availability of new medicines on the NHS and drug pricing.
Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer
Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year.
The drugmaker had pulled back projects in Britain after becoming disillusioned with the business environment, including the availability of new medicines on the NHS and drug pricing.
Coverage from 2 sources
Coverage by lean
- Unknown2
Comments
Sign in to join the discussion.
Sign in with SpryLogin